Search
for
Sort by
Research 211–240 of 1000+
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Advances and Perspectives on Bioelectronic and Atomic Nanogenerators for Anticancer Therapy
- Advances in Extraction Technologies of Silybum marianum L. and Its Role in Protecting Against Skin Damage
- Dermal Fibrosis and the Current Scope of Hydrogel Strategies for Scarless Wound Healing
- Marine-Derived Polysaccharide Nanofibers for Wound Healing: Mechanistic Rationale, Biofabrication Strategies, and Translational Barriers
- Cellulose and Its Derivatives-Based Skin Dressings: Design, Smart Advances and Applications
- Research Progress on the Immunomodulatory Effects by Dang Gui (Radix Angelica sinensis) and Its Active Chemical Components
- Bio-Nanovesicle-Based Approaches for Hair and Skin Regeneration: An Updated Concise Review
- Synergistic delivery of ginseng exosomes and biomimetic melanosomes via temporally controlled hydrogel microneedles restrain the pathologic triad of vitiligo
- The Intervention Effect of Externally Applying or Orally Administering Bifidobacterium animalis Subsp. lactis J12 on Atopic Dermatitis Induced by 2,4-Dinitrofluorobenzene
- Analysis of skin mycobiota associated with alopecia in captive cynomolgus macaques (Macaca fascicularis) based on Oxford Nanopore Technologies
- Dynamic immunomodulatory nanoarchitectonics: Rewiring tissue regenerative microenvironment via intelligent regulation
- The Potential Application of Nanocarriers in Delivering Topical Antioxidants
- Exosomal microRNA-Based therapies for skin diseases
- The Progress in Bioprinting and Its Potential Impact on Health-Related Quality of Life
- Immunosuppressive treatment for proliferative lupus nephritis
- Trichodysplasia of immunosuppression treated with oral valganciclovir
- Viral-Associated Trichodysplasia of Immunosuppression
- Symptom experience associated with immunosuppressive drugs after liver transplantation in adults: possible relationship with medication non‐compliance?
- Effects of immunosuppressive peptidyl-prolyl cis-trans isomerase (PPIase) inhibitors, cyclosporin A, FK506, ascomycin and rapamycin, on hair growth initiation in mouse: immunosuppression is not required for new hair growth
- The Anagen Hair Cycle Induces Systemic Immunosuppression of Contact Hypersensitivity in Mice
- Symptom Experience Associated With Immunosuppressive Medications in Chinese Kidney Transplant Recipients
- Immunosuppressive therapy in autoimmune disease — A review
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
- Side Effects of Transplant Immunosuppressive Therapy in Post Renal Transplant Recipients, Mazandaran, Northern Iran
- 0036 IL-27 generates immunosuppressive CD4 T cells and and prevents the development of alopecia areata
- 006 Exogenous IL-27 promotes immunosuppressive T cells and prevents the development of alopecia areata in C3H/HeJ mice
- Gender disparity among renal transplant recipients receiving immunosuppressive therapy
- Effect of immunosuppressive ppiase inhibitors, cyclosporin A, FK506, ascomycin and rapamycin on hair growth initiation
- Cytostatics and immunosuppressive drugs